Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.74 is 11% above its 5-year average of 6.07, around the middle of its 5-year range (2.35–10.25).
As of the fiscal period ended Tuesday, June 30, 2026. 9.18% above its 12-month average of 6.18.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.74.
CURRENT RATIO
6.74
CURRENT RATIO AVG TTM
6.18
CURRENT RATIO AVG 3Y
5.72
CURRENT RATIO AVG 5Y
6.07
CURRENT RATIO AVG 10Y
5.07
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.18%
CURRENT VS 3Y AVG
+17.91%
CURRENT VS 5Y AVG
+11.04%
CURRENT VS 10Y AVG
+32.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.73
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+81.07%
vs the sector median at left
Senseonics Holdings, Inc.
Market Cap
$413.34M
Current Ratio
6.74
TTM Avg
6.18
3Y Avg
5.72
5Y Avg
6.07
Market Cap
$412.21M
Current Ratio
2.64
TTM Avg
6.72
3Y Avg
6.86
5Y Avg
10.11
Market Cap
$408.82M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$407.71M
Current Ratio
10.71
TTM Avg
7.83
3Y Avg
8.94
5Y Avg
8.94
Market Cap
$422.94M
Current Ratio
3.48
TTM Avg
10.77
3Y Avg
42.35
5Y Avg
30.00
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Senseonics Holdings, Inc. (SENS) | $413.34M | 6.74 | 6.18 | 5.72 | 6.07 |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.21M | 2.64 | 6.72 | 6.86 | 10.11 |
| Myriad Genetics, Inc. (MYGN)vs › | $411.47M | 2.21 | 2.16 | 2.08 | 2.23 |
| Rezolute, Inc. (RZLT)vs › | $408.48M | 9.44 | 11.90 | 14.34 | 23.42 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.82M | 9.89 | 6.34 | 6.34 | 6.34 |
| Carlsmed, Inc. (CARL)vs › | $406.69M | 8.84 | 7.23 | 5.35 | 5.35 |
| Shoulder Innovations, Inc. (SI)vs › | $407.71M | 10.71 | 7.83 | 8.94 | 8.94 |
| Neurogene Inc. (NGNE)vs › | $405.53M | 10.64 | 18.70 | 14.71 | 15.05 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.94M | 3.48 | 10.77 | 42.35 | 30.00 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.16M | 8.13 | 16.34 | 21.67 | 17.16 |
Current Ratio
6.74
Quick Ratio
6.40
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.74 |
| 2026-03-31 | 3.51 |
| 2025-12-31 | 4.83 |
| 2025-09-30 | 6.23 |
| 2025-06-30 | 9.58 |
| 2025-03-31 | 6.88 |
| 2024-12-31 | 2.35 |
| 2024-09-30 | 2.47 |
| 2024-06-30 | 3.11 |
| 2024-03-31 | 3.96 |
| 2023-12-31 | 7.53 |
| 2023-09-30 | 8.45 |
| 2023-06-30 | 8.72 |
| 2023-03-31 | 10.25 |
| 2022-12-31 | 5.12 |
| 2022-09-30 | 2.94 |
| 2022-06-30 | 5.03 |
| 2022-03-31 | 5.10 |
| 2021-12-31 | 7.85 |
| 2021-09-30 | 7.95 |
| 2021-06-30 | 8.95 |
| 2021-03-31 | 12.20 |
| 2020-12-31 | 1.82 |
| 2020-09-30 | 3.54 |
| 2020-06-30 | 2.61 |
| 2020-03-31 | 1.71 |
| 2019-12-31 | 1.01 |
| 2019-09-30 | 7.36 |
| 2019-06-30 | 2.80 |
| 2019-03-31 | 4.56 |
| 2018-12-31 | 5.47 |
| 2018-09-30 | 8.00 |
| 2018-06-30 | 8.29 |
| 2018-03-31 | 3.58 |
| 2017-12-31 | 1.94 |
| 2017-09-30 | 2.93 |
| 2017-06-30 | 3.03 |
| 2017-03-31 | 1.40 |
| 2016-12-31 | 1.84 |
| 2016-09-30 | 2.51 |
| 2016-06-30 | 3.91 |
| 2016-03-31 | 3.73 |
| 2015-12-31 | 0.68 |
| 2015-09-30 | 0.05 |
| 2015-06-30 | 0.02 |
| 2015-03-31 | 0.79 |
| 2014-12-31 | 0.89 |
| 2014-09-30 | 0.23 |
